Literature DB >> 33122937

Elevated Serum Uric Acid is Associated with Rapid Decline in Kidney Function: A 10-Year Follow-Up Study.

Kittrawee Kritmetapak1, Suranut Charoensri2, Rattrai Thaopanya3, Chatlert Pongchaiyakul2.   

Abstract

PURPOSE: The long-term impact of changes in serum uric acid (SUA) concentration on the estimated glomerular filtration rate (eGFR) among the general population remains unclear. We investigated the longitudinal associations between changes in SUA and eGFR over 10 years in 1222 participants with baseline eGFR ≥60 mL/min/1.73 m2.
METHODS: This was a 10-year retrospective cohort study conducted from 2007 to 2017. Rapid eGFR decline (defined as the highest quartile of change in eGFR between 2007 and 2017) and new-onset kidney disease (defined as an eGFR <60 mL/min/1.73 m2 at a 10-year follow-up) were examined using multiple logistic regression analysis, adjusted for sex, age, body mass index, systolic blood pressure, SUA, fasting plasma glucose, serum total cholesterol, and triglyceride at baseline.
RESULTS: SUA was inversely correlated with eGFR, and the slopes of the SUA-eGFR regression lines were consistently steeper in females than males. A significant inverse correlation was also observed between 10-year changes in SUA and eGFR in both sexes. Multivariate analysis showed that every 1 mg/dL increase in SUA from baseline was associated with higher risk of rapid eGFR decline and new-onset kidney disease (OR 1.25; 95% CI 1.14-1.33 and OR 1.40; 95% CI 1.26-1.49, respectively). Furthermore, the subjects in the highest SUA quartile (>6.0 mg/dL) had a 2.45 times higher risk of rapid eGFR decline (95% CI 1.51-3.42) compared to those in the lowest SUA quartile (<3.9 mg/dL).
CONCLUSION: Elevated baseline SUA is an independent risk factor for rapid eGFR decline and new-onset kidney disease in the general population.
© 2020 Kritmetapak et al.

Entities:  

Keywords:  chronic kidney disease; epidemiology; glomerular filtration rate; risk factors; uric acid

Year:  2020        PMID: 33122937      PMCID: PMC7591020          DOI: 10.2147/IJGM.S277957

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  31 in total

1.  Risk factors for end-stage renal disease: 25-year follow-up.

Authors:  Chi-yuan Hsu; Carlos Iribarren; Charles E McCulloch; Jeanne Darbinian; Alan S Go
Journal:  Arch Intern Med       Date:  2009-02-23

2.  Con: Should we abandon the use of the MDRD equation in favour of the CKD-EPI equation?

Authors:  Pierre Delanaye; Hans Pottel; Rossini Botev; Lesley A Inker; Andrew S Levey
Journal:  Nephrol Dial Transplant       Date:  2013-06       Impact factor: 5.992

3.  Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Ichiro Hisatome; Koichiro Niwa; Shigeko Hara; Carlos A Roncal-Jimenez; Petter Bjornstad; Takahiko Nakagawa; Ana Andres-Hernando; Yuka Sato; Thomas Jensen; Gabriela Garcia; Bernardo Rodriguez-Iturbe; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson
Journal:  Hypertension       Date:  2017-12-04       Impact factor: 10.190

4.  Longitudinal studies on the rate of decline in renal function with age.

Authors:  R D Lindeman; J Tobin; N W Shock
Journal:  J Am Geriatr Soc       Date:  1985-04       Impact factor: 5.562

5.  Serum uric acid is not independently associated with plasma renin activity and plasma aldosterone in hypertensive adults.

Authors:  G Mulè; A Castiglia; M Morreale; G Geraci; C Cusumano; L Guarino; D Altieri; M Panzica; F Vaccaro; S Cottone
Journal:  Nutr Metab Cardiovasc Dis       Date:  2016-12-27       Impact factor: 4.222

6.  Hyperuricemia in primary and renal hypertension.

Authors:  P J Cannon; W B Stason; F E Demartini; S C Sommers; J H Laragh
Journal:  N Engl J Med       Date:  1966-09-01       Impact factor: 91.245

7.  Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kappaB.

Authors:  Ho Jae Han; Min Jin Lim; Yun Jung Lee; Jang Hern Lee; Il Suk Yang; Mary Taub
Journal:  Am J Physiol Renal Physiol       Date:  2006-09-19

8.  Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan.

Authors:  Kazufumi Nagahama; Taku Inoue; Kunitoshi Iseki; Takashi Touma; Kozen Kinjo; Yusuke Ohya; Shuichi Takishita
Journal:  Hypertens Res       Date:  2004-11       Impact factor: 3.872

9.  Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy.

Authors:  Frédéric Preitner; Olivier Bonny; Alexandra Laverrière; Samuel Rotman; Dmitri Firsov; Anabela Da Costa; Salima Metref; Bernard Thorens
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-21       Impact factor: 11.205

10.  Uric acid and long-term outcomes in CKD.

Authors:  Magdalena Madero; Mark J Sarnak; Xuelei Wang; Tom Greene; Gerald J Beck; John W Kusek; Allan J Collins; Andrew S Levey; Vandana Menon
Journal:  Am J Kidney Dis       Date:  2009-03-20       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.